Eli Lilly (LLY) PT Raised to $98 at Leerink Partners
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,156.73 -1.52%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 17
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 17
Join SI Premium – FREE
Leerink Partners raised its price target on Eli Lilly (NYSE: LLY) to $98.00 (from $95.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lilly reports one-year data on Taltz and Zepbound combined in psoriatic disease
- Pernod Ricard SA (RI:FP) (PDRDY) PT Lowered to EUR60 at Deutsche Bank
- Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
